Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Stem Cell			1.44B	1.34B	691.52M	295.38M	282.07M
Stem Cell Growth			7.54%	94.17%	134.11%	4.72%	-71.82%
Cosmetics			4.12B	4.01B	3.18B	1.28B	2.63B
Cosmetics Growth			2.69%	25.99%	149.18%	-51.41%	-52.49%
Biopharma			351.38M	562.54M	-	-	-
Biopharma Growth			-37.54%	-	-	-	-
Non-Clinical Trials			7.12B	10.48B	8.88B	8.61B	3.64B
Non-Clinical Trials Growth			-32.03%	18.07%	3.08%	136.83%	-4.51%
Inter-Sector Revenue			-332.00M	-94.34M	-345.40M	-	-541.96M
Total			12.70B	16.30B	12.40B	10.18B	6.00B
Total Growth			-22.06%	31.41%	21.81%	69.60%	-34.49%

Source: S&P Global Market Intelligence.